Results 181 to 190 of about 1,716,661 (233)

The Pleiotropic Roles of Cytokines in Chimeric Antigen Receptor T-cell Therapy. [PDF]

Cancer Immunol Res
Stewart CM, Siegler EL, Kenderian SS.
europepmc   +1 more source

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells. [PDF]

Mol Ther
Whilding LM, Parente-Pereira AC, Zabinski T, Davies DM, Petrovic RMG, Kao YV, Saxena SA, Romain A, Costa-Guerra JA, Violette S, Itamochi H, Ghaem-Maghami S, Vallath S, Marshall JF, Maher J.   +14 more
europepmc   +1 more source

Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy. [PDF]

Science
Chen Y, Liu Y, Nguyen K, Wu J, Song S, Lin K, Rodrigues PF, Du S, Zhou C, Xiong K, Bosch M, Lin PB, Khantakova D, Wu S, Wu M, Yuede C, Holtzman DM, Colonna M.   +17 more
europepmc   +1 more source

Chimeric Antigen Receptor-Immune Cell-Based Therapies for Clear Cell Renal Cell Carcinoma: Latest Advancements and Directions. [PDF]

Cancers (Basel)
Zhu X, Zhang Y, Chen Y, Li S, Wang K, Li T, Ma X, Ni Z, Jiang H.   +8 more
europepmc   +1 more source

Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis. [PDF]

Blood Adv
Wudhikarn K, Bromberg M, Brower J, Seshan V, Bachanova V, Ahmed S, McGuirk JP, Manu G, Maziarz RT, Oluwole OO, Schuster SJ, Porter DL, Bishop MR, Riedell PA, Perales MA, Dahi PB.   +15 more
europepmc   +1 more source

Editorial: Novel chimeric antigen receptor (CAR) designs in engineering NK cells for cancer. [PDF]

Front Immunol
Chan WK.
europepmc   +1 more source

Chimeric antigen receptor T-cell therapy in systemic lupus erythematosus: From B cell depletion to immune reprogramming. [PDF]

J Transl Autoimmun
Zhao W, Chen M, Long J, Lu P, Jin J.
europepmc   +1 more source

Auto-inducible expression of chimeric antigen receptor T cells using the NR4A1 promoter. [PDF]

Immunol Cell Biol
Smith-Bell SW, Halpin JC, Darcy PK, Liyanage T, Dobson LJ, McLellan AD.   +5 more
europepmc   +1 more source

Development of Chimeric Antigen Receptor-Modified NK Cells for the Immunotherapy of Adult T-Cell Leukemia/Lymphoma. [PDF]

Eur J Haematol
Uchida Y, Tateo S, Wakao M, Shinchi H, Sawayama H, Fukumoto A, Yoshimitsu M, Suda Y.   +7 more
europepmc   +1 more source

Development and characterization of anti-CXCR4 chimeric antigen receptor T cells. [PDF]

Transl Oncol
Seir G, Bubb QR, Sotillo E, Gruber T, Richards RM, Czechowicz A.   +5 more
europepmc   +1 more source